Intracellular acidification abrogates the heat shock response and compromises survival of human melanoma cells.
This study tests the hypothesis that lowering intracellular pH (pHi) in melanoma cells grown at low extracellular pH (pHe) selectively abrogates 42 degrees C-induced heat shock protein (HSP) expression and reduces survival. Cells were acidified by a combination of a 0.2-pH-unit decrease in pHe coupled with the lactate/H+ transport inhibitor alpha-cyano-4-hydroxy-cinnamic acid (CNCn). A mild acute extracellular acidification was used to mimic the acute extracellular acidification observed in tumors that can be induced in vivo by oral glucose administration. CNCn blocks the activity of H(+)-linked monocarboxylate transporters (MCTs), particularly MCT isoform 1 (MCT-1). This transporter removes lactic acid from cells and has a high activity in DB-1 melanoma cells grown at low pHe. The effect of extracellular acidification combined with CNCn on pHi was measured in cells grown at pHe 6.7 and pHe 7.3. Cells grown at pHe 6.7 serve as an in vitro model for cells in an acidic tumor microenvironment. When cells were grown at pHe 6.7 and incubated with CNCn at pHe 6.5, the pHi decreased from 6.9 to below 6.5, and the 42 degrees C induction of HSP70 and HSP27 was blocked. The abrogation of HSP induction correlated positively with decreased clonogenic survival. In contrast, when cells growing at pHe 7.3 were acidified by a 0.2-pH unit to pHe 7.1, the inhibitor had less effect on pHi, which remained above 7.0. Under these conditions, the 42 degrees C-induction of HSPs was not inhibited, and cytotoxicity was not enhanced. These results indicate that a significant decrease in the pHi of melanoma cells can selectively sensitize the cells to 42 degrees C hyperthermia, possibly through the inhibition of HSP expression. This strategy could result in a therapeutic gain, because normal tissues, existing at a pHe above 7.0, would not be sensitized.
Coss
Ronald A
RA
Department of Radiation Oncology, and the Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA. ronald.coss@mail.tju.edu
Storck
Christopher W
CW
Daskalakis
Constantine
C
Berd
David
D
Wahl
Miriam L
ML
D015153:Blotting, Western; D045744:Cell Line, Tumor; D002470:Cell Survival; D004396:Coloring Agents / Q000494:pharmacology; D003373:Coumaric Acids / Q000494:pharmacology; D004591:Electrophoresis, Polyacrylamide Gel; D055551:HSP27 Heat-Shock Proteins; D018840:HSP70 Heat-Shock Proteins / Q000378:metabolism; D006360:Heat-Shock Proteins; D006358:Hot Temperature; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008545:Melanoma / Q000473:pathology* / Q000628:therapy; D008856:Microscopy, Fluorescence; D018832:Molecular Chaperones; D027501:Monocarboxylic Acid Transporters / Q000378:metabolism; D009363:Neoplasm Proteins / Q000378:metabolism; D020033:Protein Isoforms; D027981:Symporters / Q000378:metabolism; D013696:Temperature; D013997:Time Factors; D014407:Tumor Cells, Cultured; D000099233:Monocarboxylate Transport Protein 1
D004396:Coloring Agents; D003373:Coumaric Acids; D055551:HSP27 Heat-Shock Proteins; D018840:HSP70 Heat-Shock Proteins; D006360:Heat-Shock Proteins; D018832:Molecular Chaperones; D027501:Monocarboxylic Acid Transporters; D009363:Neoplasm Proteins; D020033:Protein Isoforms; D027981:Symporters; D000099233:Monocarboxylate Transport Protein 1; C057725:HSPB1 protein, human; C007175:alpha-cyano-4-hydroxycinnamate